ArticleAnnals of medicine and surgery (2012)2026

FDA approval of copper histidinate (Zycubo) for Menkes disease: a therapeutic breakthrough in a rare pediatric neurodegenerative disorder.

Muhammad Hammad Ghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.